Treatment Tapering in JIA With Inactive Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

May 18, 2017

Primary Completion Date

October 29, 2019

Study Completion Date

October 1, 2020

Conditions
Juvenile Idiopathic Arthritis
Interventions
DRUG

etanercept

will be tapered from every week to every 2 weeks for 12 weeks then to every 3 weeks for 12 weeks

DRUG

adalimumab

will be tapered from every 2 weeks to every 3 weeks for 12 weeks and to every 4 weeks for 12 weeks

DRUG

Abatacept

will be tapered from every 4 weeks to every 6 weeks for 24 weeks

DRUG

Tocilizumab

will be tapered from every 4 weeks to every 6 weeks for 24 weeks

Trial Locations (1)

75015

Necker Children's Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02840175 - Treatment Tapering in JIA With Inactive Disease | Biotech Hunter | Biotech Hunter